US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer.
| Autor: | Shah, Mirat, Lingam, Hima, Gao, Xin, Gittleman, Haley, Fiero, Mallorie H., Krol, Danielle, Biel, Nikolett, Ricks, Tiffany K., Fu, Wentao, Hamed, Salaheldin, Li, Fang, Sun, Jillian, Fan, Jianghong, Schuck, Robert, Grimstein, Manuela, Tang, Liuya, Kalavar, Shyam, Abukhdeir, Abdelrahmman, Pathak, Anand, Ghosh, Soma |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 4/1/2024, Vol. 42 Issue 10, p1193-1201, 10p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|